News

AAR Corp's Upcoming Earnings: What Investors Need to Know

AAR Corp's Upcoming Earnings: What Investors Need to Know

Anticipating AAR Corp's Earnings Report

AAR Corp (NYSE: AIR) is gearing up to unveil its quarterly earnings report soon. Investors are eagerly anticipating this announcement as it provides critical insight into the company's financial trajectory and operational effectiveness. With expectations high, analysts predict an earnings per share (EPS) of $1.00 for the upcoming quarter.

Latest Financial Insights

Investors are keenly awaiting AAR's performance metrics, particularly to see if it can surpass the current EPS estimates. Positive guidance could indicate a promising outlook for the next quarter, which would be welcomed news for shareholders.

Earnings History

In the previous earnings report, AAR surpassed expectations, achieving an EPS of $0.99, delighting investors. This unexpected growth, however, was followed by a 16.4% drop in the share price the next trading day, highlighting the volatile nature of investor reactions to financial news.

Cumulative EPS Performance

To provide context, here's a summary of AAR's recent earnings track record:

Quarterly Performance:

  • Q3 2025: EPS Estimate: 0.96, EPS Actual: 0.99, Price Change: -16.0%
  • Q2 2025: EPS Estimate: 0.84, EPS Actual: 0.90, Price Change: +9.0%
  • Q1 2025: EPS Estimate: 0.82, EPS Actual: 0.85, Price Change: -5.0%
  • Q4 2024: EPS Estimate: 0.86, EPS Actual: 0.88, Price Change: -12.0%

Current Stock Dynamics

As of July 14, shares of AAR were priced at $74.72, reflecting a slight increase of 0.29% over the past year. This stability, combined with an optimistic market sentiment, suggests that long-term investors may have a favorable view going into the earnings report.

Investor Sentiment and Analyst Ratings

Investor sentiments play a vital role in shaping stock performance. Analysts currently rate AAR with a consensus of “Buy,” and the average one-year price target is $81.0, which presents an upside potential of around 8.4% from the current price.

Comparative Analysis in the Sector

In the competitive landscape, AAR's performance is compared against three significant industry players: Mercury Systems, V2X, and Cadre Holdings.

  • Mercury Systems holds a Neutral rating with a one-year price target of $50.8, indicating a potential downside of 32.01%.
  • V2X has a Buy recommendation with a one-year price target of $55.0, suggesting a downside risk of 26.39%.
  • Cadre Holdings is also rated Neutral, with a price target of $38.0, presenting a downside of 49.14%.

AAR’s Competitive Edge

Despite the challenges facing AAR, the firm leads its peers regarding revenue growth rate, reported at 19.55%. However, the company’s gross profit is $131.70M, positioning it on the lower end overall compared to its competitors.

A Deeper Look into AAR’s Operations

AAR Corp primarily serves the aviation, government, and defense sectors through its varied offerings, which include Parts Supply, Repair & Engineering, and Integrated Solutions. The company excels in parts sales and leasing, with a strong emphasis on aftermarket distribution of OEM-supplied parts. The Repair & Engineering division focuses on essential maintenance activities, while Integrated Solutions emphasizes fleet management and logistical support.

Financial Health Overview

AAR showcases a unique position in the market with the following financial statistics:

Market Capitalization: Currently positioned below industry averages due to its limited market size.

Revenue Growth: AAR recorded a significant revenue growth of 19.55% over the recent quarter, indicating a robust increase in top-line earnings.

Net Margin and Returns: The current net margin reveals challenges, standing at -1.31%. Similarly, AAR's return on equity (ROE) is reported at -0.75%, indicating the need for improved efficiency in capital utilization.

Asset Management: AAR's return on assets (ROA) is currently below industry norms at -0.31%, showcasing difficulties in asset utilization efficiency.

Debt-to-Equity Ratio: AAR’s debt-to-equity ratio is at 0.92, suggesting a higher reliance on borrowed funds than its industry peers, which raises concerns about financial leverage.

Final Thoughts

As investors await AAR Corp's quarterly earnings announcement, monitoring these key indicators and market sentiments will provide insight into the company's future direction and investment potential.

Frequently Asked Questions

What is the expected EPS for AAR Corp's upcoming earnings?

The anticipated earnings per share (EPS) for AAR Corp is projected to be $1.00.

How did AAR perform in its last earnings report?

AAR surpassed the EPS estimate of $0.96, reporting an actual EPS of $0.99. However, it experienced a significant share price drop of 16.0% following the announcement.

What is AAR Corp's current share price?

As of July 14, the share price of AAR Corp was $74.72.

What is the consensus rating from analysts on AAR Corp?

AAR Corp currently holds a consensus rating of Buy from analysts, indicating a positive outlook.

How does AAR Corp perform compared to its industry peers?

AAR leads in revenue growth at 19.55%, despite having challenges with profitability metrics compared to its peers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 80

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 14

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 0

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 35

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 112

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Faith on Trial: La Luz del Mundo Faces Court Ruling

Updated Category News Views 21

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 194

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 0

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Honeywell Aerospace Posts Solid Q3, Raises Guidance

Updated Category News Views 39

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyxis Oncology Focuses on Breakthrough Therapy PYX-201

Updated Category News Views 205

Pyxis Oncology Redirects Focus to Leading Therapy PYX-201 Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotech firm, has announced a significant shift in its strategic direction by prioritizing its lead clinical program, PYX-201. This innovative antibody-drug conjugate (ADC) is engineered to target specific components within the tumor extracellular matrix, aiming...

Continue Reading
Ecovyst's Q3 Performance and Strategic Moves for Growth

Updated Category News Views 98

Ecovyst's Third Quarter Performance and Strategic Insights Ecovyst Inc. (NYSE: ECVT), a notable provider in the chemical industry, recently revealed its financial performance for the third quarter of 2025, showcasing significant progress in its operations and strategic decisions. The company specializes in the production of virgin sulfuric acid and regeneration services,...

Continue Reading
Consumer Interest Grows for Monthly AI Home Assistant Services

Updated Category News Views 447

Consumer Willingness to Invest in AI-Driven Home Solutions Recent research into consumer preferences reveals that a significant portion of the population is ready to embrace AI-assisted smart home technology. Parks Associates' compelling study finds that between 42% and 52% of consumers are inclined to subscribe to a monthly service for an AI smart home assistant that...

Continue Reading
Tuya Smart Introduces Hey Tuya: Revolutionizing Everyday AI Assistants

Updated Category News Views 186

Tuya Smart Unveils Hey Tuya: A Game-Changer in AI Technology In a notable advancement in AI technology, Tuya Smart (NYSE: TUYA) has introduced its innovative platform called Hey Tuya. This next-generation Super AI Life Assistant is set to redefine how individuals interact with artificial intelligence in their daily lives. The initiative represents a significant leap...

Continue Reading
Innovative Food Packaging Concept Redefines Convenience

Updated Category News Views 384

New Approach to Food and Beverage Packaging In an ever-evolving world where efficiency and convenience are paramount, an inventive solution has emerged. An inventor, motivated by the challenges of transporting, preparing, and storing food, has conceptualized an improved packaging design that promises to revolutionize these everyday tasks. Why This Invention Matters This...

Continue Reading